John Kautter

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Incorporating prescription drugs into Affordable Care Act risk adjustment

A comparison of health risk and costs across private insurance markets

Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010-2013

21-Gene recurrence score testing among Medicare beneficiaries with breast cancer in 2010-2013

Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data

Identifying code stacking among complex diagnostic laboratory tests in Medicare claims data

Utilization of the 21-Gene Rs Test Among Medicare Beneficiaries with Breast Cancer in 2011

Financial and quality impacts of the medicare physician group practice demonstration

Competitive bidding for Medicare Part B clinical laboratory services

Affordable Care Act risk adjustment: Overview, context, and challenges

The HHS-HCC risk adjustment model for individual and small group markets under the Affordable Care Act

Risk transfer formula for individual and small group markets under the affordable care act

Improvements in Medicare Part D risk adjustment: Beneficiary access and payment accuracy

Minimum savings requirements in shared savings provider payment

Minimum Savings Requirement in Shared Savings Provider Payment

The national market for Medicare clinical laboratory testing: Implications for payment reform

Pioneer ACO alignment and financial reconciliation methods, version 7.1

Incorporating efficiency measures into pay for performance

Medicare risk adjustment for the frail elderly

Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries